Buy stocks
Invest and track all your stocks in one place.
Aurobindo Pharma LtdNSE: AUROPHARMA
NSE: AUROPHARMA
₹1,197.50
-37.55
(27 May)
-3.0%
Loading chart
1D
1W
3M
1Y
5Y
Price
₹1,197.50
Today’s high
₹1,238.45
Today’s low
₹1,191.25
52W high
₹1,245.60
52W low
₹584.55
1Y
94.9%
PE
25.35
PB
2.49
EPS (TTM)
32.90
Dividend yield
0.4%
5Y
13.1%
Market cap
₹70,166.1 Cr
Volume
1,11,827
Average volume
48,583
Insights
AUROPHARMA has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
AUROPHARMA price is above its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
₹1,615.00
₹1,197.50
₹5,322.40
₹1,466.70
₹5,875.90
₹4,254.70
1D
+0.1%
-3.0%
-2.3%
-1.3%
+0.2%
+3.2%
1Y
+107.1%
+94.9%
+59.1%
+51.1%
+29.7%
+21.2%
PE
38.57
25.35
40.45
36.76
18.76
81.65
PB
5.15
2.49
6.47
5.53
3.46
8.91
EPS
41.87
47.24
131.57
39.90
313.29
52.11
Market cap
Large
Large
Large
Large
Large
Large
Financials
Income statement
Balance sheet
Cash flow
Quarterly
Annual
As of 2022
Revenue
₹24,617.1 Cr
Net income
₹1,927.5 Cr
See stock holdings
Top institutional holders
HDFC Asset Management Co Ltd
3.80%
ICICI Prudential Asset Management Company Limited
3.42%
HDFC Asset Management Company Limited
3.00%
Mirae Asset Global Inv (India) Pvt. Ltd
2.81%
Quant Money Managers Limited
2.54%
Top mutual fund holders
HDFC Mid-Cap Opportunities
2.05%
Invesco Asian Fund (UK)
0.96%
HDFC Hybrid Equity Fund
0.92%
Quant Mid Cap Fund
0.90%
Mirae Asset Large & Midcap Fund
0.85%
About Aurobindo Pharma
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. The company's product portfolio spans a variety of therapeutic areas. The vast majority of the company's sales are generated in the United States, followed by Europe. Most of Aurobindo's sales are derived from its formulations business, with the rest stemming from its active pharmaceutical ingredient operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Company address
Plot No. 1, Survey No. 83/1, Galaxy, Floors: 22-24, Hyderabad, TG, 500
Key executives
Name
Title
Age
Mr. N. Govindarajan
Director/Managing Director
53 yrs
Mr. K. Nithyananda Reddy
Director/Managing Director/Vice Chairman of the Board
64 yrs

FAQs

How to Buy Aurobindo Pharma Ltd Stock?
What is the Share Price of Aurobindo Pharma Ltd?
What is the Market Cap of Aurobindo Pharma Ltd?
In which sector / industry does Aurobindo Pharma Ltd operate?
What was the revenue of Aurobindo Pharma Ltd?
What is the PE ratio of Aurobindo Pharma Ltd?
What is the 52 week high price of Aurobindo Pharma Ltd?
What is the 52 week low price of Aurobindo Pharma Ltd?
Can fractional shares of Aurobindo Pharma Ltd be purchased?